Literature DB >> 15716154

Apolipoprotein E and category fluency: evidence for reduced semantic access in healthy normal controls at risk for developing Alzheimer's disease.

Virginia M Rosen1, Trey Sunderland, James Levy, Angela Harwell, Lori McGee, Christopher Hammond, Deepa Bhupali, Karen Putnam, Judy Bergeson, Charlene Lefkowitz.   

Abstract

Two groups of non-demented individuals, who differed on genetic risk for Alzheimer's disease (AD) based on their apolipoprotein E (APOE) genotype, were tested on a category fluency task. Twenty varepsilon4 carriers and twenty varepsilon4 non-carriers were tape recorded while saying animal names for ten minutes. Five measures were examined: total names generated; total clusters; mean cluster size; mean within-cluster retrieval time; and mean between-cluster retrieval time. Groups were matched on age and education and scored as normal on a battery of psychometric tests. The varepsilon4 carriers generated significantly fewer names and clusters, and took significantly longer to access clusters, when compared to the varepsilon4 non-carriers. No group differences were found for cluster size or within-cluster retrieval times. We previously reported [Rosen, V. M., Bergeson, J. L., Putnam, K., Harwell, A., Sunderland, T. (2002). Working memory and apolipoprotein E: What's the connection? Neuropsychologia 40, 2226-2233] that the varepsilon4 carriers in the present study scored significantly lower than the varepsilon4 non-carriers on a measure of working memory/attentional capacity [Operation Span Task, see Turner, M. L., Engle, R. W. (1989). Is working memory capacity task dependent? Journal of Memory and Language 28, 127-154]. In the present study, a significant negative relationship found between span performance and between-cluster retrieval times suggested that reduced attentional capacity may have negatively impacted semantic access for the varepsilon4 carriers. Finally, we found significant relationships between a Trail Making Test [Reitan, R. M. (1992). Trail Making Test, manual for administration and scoring. Tucson, AZ: Reitan Neuropsychology Laboratory] "switch" measure (Form B-Form A) and three of the five fluency measures. The findings suggested that the varepsilon4 carrier's reduced attentional capacity may have interfered with their covertly shifting attention among subcategories in the fluency task, resulting in fewer names and clusters generated and longer times to access clusters.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15716154     DOI: 10.1016/j.neuropsychologia.2004.06.022

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  17 in total

1.  Increased functional brain response during word retrieval in cognitively intact older adults at genetic risk for Alzheimer's disease.

Authors:  Christina E Wierenga; Nikki H Stricker; Ashley McCauley; Alan Simmons; Amy J Jak; Yu-Ling Chang; Lisa Delano-Wood; Katherine J Bangen; David P Salmon; Mark W Bondi
Journal:  Neuroimage       Date:  2010-03-16       Impact factor: 6.556

Review 2.  Neuropsychological contributions to the early identification of Alzheimer's disease.

Authors:  Mark W Bondi; Amy J Jak; Lisa Delano-Wood; Mark W Jacobson; Dean C Delis; David P Salmon
Journal:  Neuropsychol Rev       Date:  2008-03-18       Impact factor: 7.444

3.  Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension.

Authors:  Naftali Raz; Karen M Rodrigue; Kristen M Kennedy; Susan Land
Journal:  Neuropsychology       Date:  2009-01       Impact factor: 3.295

4.  Verbal Fluency and Early Memory Decline: Results from the Wisconsin Registry for Alzheimer's Prevention.

Authors:  Kimberly Diggle Mueller; Rebecca L Koscik; Asenath LaRue; Lindsay R Clark; Bruce Hermann; Sterling C Johnson; Mark A Sager
Journal:  Arch Clin Neuropsychol       Date:  2015-05-29       Impact factor: 2.813

5.  Spatial pattern separation differences in older adult carriers and non-carriers for the apolipoprotein E epsilon 4 allele.

Authors:  David P Sheppard; Lisa V Graves; Heather M Holden; Lisa Delano-Wood; Mark W Bondi; Paul E Gilbert
Journal:  Neurobiol Learn Mem       Date:  2015-05-05       Impact factor: 2.877

6.  Biomarker validation of a decline in semantic processing in preclinical Alzheimer's disease.

Authors:  Kathryn V Papp; Elizabeth C Mormino; Rebecca E Amariglio; Catherine Munro; Alex Dagley; Aaron P Schultz; Keith A Johnson; Reisa A Sperling; Dorene M Rentz
Journal:  Neuropsychology       Date:  2015-11-23       Impact factor: 3.295

7.  The utility of intraindividual variability in selective attention tasks as an early marker for Alzheimer's disease.

Authors:  Janet M Duchek; David A Balota; Chi-Shing Tse; David M Holtzman; Anne M Fagan; Alison M Goate
Journal:  Neuropsychology       Date:  2009-11       Impact factor: 3.295

8.  Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype.

Authors:  Marilyn Albert; Anja Soldan; Rebecca Gottesman; Guy McKhann; Ned Sacktor; Leonie Farrington; Maura Grega; Raymond Turner; Yi Lu; Shanshan Li; Mei-Cheng Wang; Ola Selnes
Journal:  Curr Alzheimer Res       Date:  2014       Impact factor: 3.498

9.  The utility of placing recollection in opposition to familiarity in early discrimination of healthy aging and very mild dementia of the Alzheimer's type.

Authors:  Chi-Shing Tse; David A Balota; Sarah C Moynan; Janet M Duchek; Larry L Jacoby
Journal:  Neuropsychology       Date:  2010-01       Impact factor: 3.295

10.  Apolipoprotein E and change in episodic memory in blacks and whites.

Authors:  L L Barnes; Z Arvanitakis; L Yu; J Kelly; P L De Jager; D A Bennett
Journal:  Neuroepidemiology       Date:  2013-01-24       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.